1. Home
  2. UG vs ELEV Comparison

UG vs ELEV Comparison

Compare UG & ELEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UG
  • ELEV
  • Stock Information
  • Founded
  • UG 1942
  • ELEV 2019
  • Country
  • UG United States
  • ELEV United States
  • Employees
  • UG N/A
  • ELEV N/A
  • Industry
  • UG Package Goods/Cosmetics
  • ELEV Biotechnology: Pharmaceutical Preparations
  • Sector
  • UG Consumer Discretionary
  • ELEV Health Care
  • Exchange
  • UG Nasdaq
  • ELEV Nasdaq
  • Market Cap
  • UG 45.5M
  • ELEV 37.6M
  • IPO Year
  • UG N/A
  • ELEV 2021
  • Fundamental
  • Price
  • UG $9.66
  • ELEV $0.63
  • Analyst Decision
  • UG
  • ELEV Strong Buy
  • Analyst Count
  • UG 0
  • ELEV 5
  • Target Price
  • UG N/A
  • ELEV $7.20
  • AVG Volume (30 Days)
  • UG 12.1K
  • ELEV 720.2K
  • Earning Date
  • UG 11-08-2024
  • ELEV 11-06-2024
  • Dividend Yield
  • UG 6.06%
  • ELEV N/A
  • EPS Growth
  • UG 38.11
  • ELEV N/A
  • EPS
  • UG 0.76
  • ELEV N/A
  • Revenue
  • UG $12,312,275.00
  • ELEV N/A
  • Revenue This Year
  • UG N/A
  • ELEV N/A
  • Revenue Next Year
  • UG N/A
  • ELEV N/A
  • P/E Ratio
  • UG $13.01
  • ELEV N/A
  • Revenue Growth
  • UG 11.51
  • ELEV N/A
  • 52 Week Low
  • UG $6.75
  • ELEV $0.44
  • 52 Week High
  • UG $16.25
  • ELEV $5.83
  • Technical
  • Relative Strength Index (RSI)
  • UG 36.52
  • ELEV 49.52
  • Support Level
  • UG $9.70
  • ELEV $0.61
  • Resistance Level
  • UG $9.95
  • ELEV $0.70
  • Average True Range (ATR)
  • UG 0.30
  • ELEV 0.08
  • MACD
  • UG 0.12
  • ELEV 0.00
  • Stochastic Oscillator
  • UG 22.85
  • ELEV 25.10

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

About ELEV Elevation Oncology Inc. Common stock

Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.

Share on Social Networks: